Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy
Ultrasound in Obstetrics & Gynecology · 2025
DOI: 10.1002/uog.70095 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2025. Verfasst von C Trilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Institut d'Investigació Biomèdica Sant Pau - IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, …. Hauptthemen laut MEDLINE: Aspirin, Uterine Artery, Pre-Eclampsia, Placenta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the impact of low‐dose aspirin (LDA) on placental size and uterine artery pulsatility index (UtA‐PI) by analyzing longitudinal changes between the first and second trimesters in pregnancies at high risk for early‐onset pre‐eclampsia (PE).
Methods
This was a prospective observational cohort study of 631 singleton pregnancies. Women at high risk of early‐onset PE (delivery ≤ 33 + 6 weeks) were identified using maternal factors or a multivariate screening protocol and were prescribed LDA. Placental size was assessed using two‐ and three‐dimensional ultrasonography, and UtA‐PI was measured using transabdominal Doppler, with measurements obtained in the first and second trimesters. Differences in placental measurements and UtA‐PI between high‐risk women receiving LDA and low‐risk untreated women were analyzed.
Results
Among the 631 participants, 53 (8.4%) women were prescribed LDA for the prevention of early‐onset PE. Placental size in the first trimester was significantly smaller in the LDA group compared with the untreated group, as exemplified by placental volume (mean ± SD, 68.46 ± 25.19 cm 3 vs 76.31 ± 23.63 cm 3 ; P = 0.022), and this trend persisted into the second trimester. However, no significant differences in placental growth from the first to the second trimester were observed between the groups. UtA‐PI was significantly higher in the LDA group in both trimesters, but a greater decrease in UtA‐PI multiples of the median values between trimesters was noted in these women (mean ± SD, –14.0 ± 0.28% vs –4.5 ± 0.31%; P = 0.021). Perinatal outcomes were similar between the groups, with the exception of a higher rate of Cesarean delivery in the LDA group (38.5% vs 21.1%; P = 0.008).
Conclusions
Women at high risk for early‐onset PE have a smaller placenta and higher UtA‐PI in the first and second trimesters. Treatment of high‐risk women with LDA did not affect placental growth but was associated with a greater reduction in UtA‐PI, suggesting a positive effect of LDA on placental perfusion. These findings provide insight into the mechanism of action of LDA in the prevention of PE. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Institut d'Investigació Biomèdica Sant Pau - IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin Network (RICORS, RD21/0012/0001), Instituto de Salud Carlos III, Madrid, Spain.
- Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Zitieren
APA
Trilla, C., Platero, J., Mora, J., Nan, M. N., Medina, C., Alejos, O., Parra, J., & Llurba, E. (2025). Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.70095
Vancouver
Trilla C, Platero J, Mora J, Nan MN, Medina C, Alejos O, et al. Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy. Ultrasound in Obstetrics & Gynecology. 2025. doi:10.1002/uog.70095
BibTeX
@article{Trilla2025,
author = {Trilla, C and Platero, J and Mora, J and Nan, M N and Medina, C and Alejos, O and Parra, J and Llurba, E},
title = {Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2025},
doi = {10.1002/uog.70095}
}
EUVIMED